Updated Oct 9, 2026 · 04:30 UTC
MRKMerck & Co Inc
Health Care · United States · XNYS · pharmaceutical preparations
$142.39−0.29%last session · market closed
Market cap
$351.30b
real-world
Tokenized
$270k
<0.001% of the asset
Avg token price
$144.27
+1.32% vs real
Spot volume, 24h
$150k
6 venues
Derivatives, 24h
$3.0m
0.3% of real volume
Perp open interest
$4.2m
24 venues
In DeFi
—
MRK · Price
Oct 24, 2025low $83.72 · high $153.81 · now $138.91Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $2.14 (5 analysts)
Last earnings, Aug 4
−$0.13 EPS
+50.0% vs −$0.26 forecast · Jun 2026 quarter
Real market
Merck & Co., Inc.
Last close
$142.79
Oct 7
Traded on Oct 7
$907.7m
Price now
$142.39
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $150k · 6 venues
Blynex1 pair$147k
De¹1 pair$3k
Uniswap v3 (X Layer)1 pair$900Derivatives · $3.0m · 24 venues · $4.2m open interest
BingX1 pair · OI $835k · funding +0.0050%$1.2m
Ourbit1 pair · OI $15k · funding +0.0000%$382k
Binance1 pair · OI $73k · funding +0.0000%$250kOnchain versions
3 tokens from 2 issuers
MRKXBacked Assets$140.71$252k
MRKonOndo Assets$144.24$16k
WMRKXBacked Assets$144.50$2kBy chain
Where the tokens circulate, issuers’ unsold stock taken off
TON54%$145k
Solana32%$87k
Ethereum8.7%$23k
Ink2.8%$7k
BNB Chain1.4%$4k
X Layer0.9%$2kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$66.57b
+5% YoY
Net income
$3.17b
5% margin · −81% YoY
EPS, diluted
$1.28
−80% YoY
Cash and balance sheet
Free cash flow
$16.06b
24% of revenue
Net debt
$45.54b
$8.36b cash and securities, $53.91b debt
Diluted shares
2.47b
−2% YoY
Valuation at today’s market cap
P/E
111×
EV / sales
6.0×
enterprise value $396.84b
Free cash flow yield
4.6%
Quarterly
RevenueNet income